Suppr超能文献

老年肾衰竭患者开始透析与继续内科治疗对生存和居家时间的影响:一项目标试验模拟研究。

Effect of Starting Dialysis Versus Continuing Medical Management on Survival and Home Time in Older Adults With Kidney Failure : A Target Trial Emulation Study.

机构信息

Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California (M.E.M., E.F.).

Geriatric Research, Education, and Clinical Center, Veterans Affairs Palo Alto, Palo Alto, California (I.-C.T.).

出版信息

Ann Intern Med. 2024 Sep;177(9):1233-1243. doi: 10.7326/M23-3028. Epub 2024 Aug 20.

Abstract

BACKGROUND

For older adults with kidney failure who are not referred for transplant, medical management is an alternative to dialysis.

OBJECTIVE

To compare survival and home time between older adults who started dialysis at an estimated glomerular filtration rate (eGFR) less than 12 mL/min/1.73 m and those who continued medical management.

DESIGN

Observational cohort study using target trial emulation.

SETTING

U.S. Department of Veterans Affairs, 2010 to 2018.

PARTICIPANTS

Adults aged 65 years or older with chronic kidney failure and eGFR below 12 mL/min/1.73 m who were not referred for transplant.

INTERVENTION

Starting dialysis within 30 days versus continuing medical management.

MEASUREMENTS

Mean survival and number of days at home.

RESULTS

Among 20 440 adults (mean age, 77.9 years [SD, 8.8]), the median time to dialysis start was 8.0 days in the group starting dialysis and 3.0 years in the group continuing medical management. Over a 3-year horizon, the group starting dialysis survived 770 days and the group continuing medical management survived 761 days (difference, 9.3 days [95% CI, -17.4 to 30.1 days]). Compared with the group continuing medical management, the group starting dialysis had 13.6 fewer days at home (CI, 7.7 to 20.5 fewer days at home). Compared with the group continuing medical management and forgoing dialysis completely, the group starting dialysis had longer survival by 77.6 days (CI, 62.8 to 91.1 days) and 14.7 fewer days at home (CI, 11.2 to 16.5 fewer days at home).

LIMITATION

Potential for unmeasured confounding due to lack of symptom assessments at eligibility; limited generalizability to women and nonveterans.

CONCLUSION

Older adults starting dialysis when their eGFR fell below 12 mL/min/1.73 m who were not referred for transplant had modest gains in life expectancy and less time at home.

PRIMARY FUNDING SOURCE

U.S. Department of Veterans Affairs and National Institutes of Health.

摘要

背景

对于未接受移植的肾衰竭老年患者,除透析外,还可选择药物治疗。

目的

比较肾小球滤过率(eGFR)估计值<12 ml/min/1.73 m 时开始透析与继续药物治疗的老年患者的生存情况和居家时间。

设计

使用目标试验模拟的观察性队列研究。

设置

2010 年至 2018 年,美国退伍军人事务部。

参与者

年龄≥65 岁,慢性肾衰竭且 eGFR<12 ml/min/1.73 m ,且未接受移植的患者。

干预措施

在 30 天内开始透析与继续药物治疗。

测量指标

平均生存时间和居家天数。

结果

在 20440 例成人患者(平均年龄 77.9 岁[标准差 8.8])中,开始透析组的中位时间为 8 天,继续药物治疗组为 3 年。在 3 年的时间里,开始透析组的患者存活了 770 天,继续药物治疗组存活了 761 天(差值 9.3 天[95%CI,-17.4 至 30.1 天])。与继续药物治疗组相比,开始透析组的居家天数减少了 13.6 天(CI,7.7 至 20.5 天)。与继续药物治疗组和完全不透析相比,开始透析组的生存时间延长了 77.6 天(CI,62.8 至 91.1 天),居家时间减少了 14.7 天(CI,11.2 至 16.5 天)。

局限性

由于在入选时缺乏症状评估,可能存在未测量的混杂因素;对女性和非退伍军人的适用性有限。

结论

对于未接受移植的肾小球滤过率(eGFR)<12 ml/min/1.73 m 的肾衰竭老年患者,开始透析可适度提高预期寿命并减少居家时间。

主要资金来源

美国退伍军人事务部和美国国立卫生研究院。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验